Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07116564

Impact of ERAS Protocol on Length of Hospital Stay After Laparoscopic Surgeries

The goal of this clinical trial is to determine the length of hospital stay in patients using multimodal analgesia with or without ERAS protocol scheduled for elective laparoscopic gynecological surgeries

Recruiting

Interested in participating?

Request Info

Key information

Conditions

ERAS

Age range

20 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Aga Khan University, Karachi, Pakistan

Karachi, Sindh, Pakistan

Location status: Recruiting

Location contact

Ali Sarfraz Siddiqui, FCPS, MHPE

CONTACT

[email protected]

009234864397 ext. 4397

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ASA physical status I, II, and III
  • Patients scheduled for elective laparoscopic gynecological surgeries

Exclusion criteria

  • Refusal to participate
  • History of allergy or contraindication to study drugs
  • Patients in which procedure converted to open surgery
  • Diagnostic laparoscopic procedures
  • Patients with a history of severe anxiety or depression

Treatment and study plan

Enhanced Recovery After Surgery

Drug

Preoperatively ERAS protocol includes, No solid food for 6 hours before procedure; 800 ml (fantomalt powder) Carbohydrate drink 8 hours before surgery; 400 ml (fantomalt powder) 2 hours before surgery; Celecoxib 200g 1 hour before surgery . Intraoperatively, on induction lidocaine 1.5 mg/kg and Fentanyl 1 to 2 mcg/kg followed by IV lidocaine infusion at 1.5 mg/kg/h.

Control

Drug

Preoperatively, NPO 6 hours before the procedure Intraoperatively, on induction Nabuphine 0.1mg/kg

Primary outcomes

  1. Length of hospital stay

    Time frame: From arrival in the recovery room post-surgery until 72 hours after surgery.

    Post-operative length of hospital stay, measured in hours from the patient's arrival in the recovery room until 72 hours after surgery.

Secondary outcomes

  1. Postoperative pain score

    Time frame: 4 hours, 8 hours, 12 hours, 24 hours, 48 hours & 72 hours postoperatively

    Post operative pain score will be measures using NRS (Numerical Rating Scale). Eleven points pain scale measures from 0-10, where "0" is no pain and "10" is the worst possible pain

  2. Amount of opioid used in patient controlled analgesia

    Time frame: 12 hours postoperatively.

    Total Nalbuphine consumption in 12 hours (in milligrams)

  3. Patient satisfaction Score

    Time frame: 24 hours after the operation

    Patient satisfaction with the pain management regimen will be assessed using a five-point Likert scale 24 hours after surgery. The scale ranges from 1 to 5, where 1 = Very Dissatisfied, 2 = Dissatisfied, 3 = Neutral, 4 = Satisfied, and 5 = Very Satisfied. Higher scores indicate greater satisfaction.

Study contacts

Contact information is provided by the study sponsor or research team.

Ali Sarfraz Siddiqui, MBBS, MCPS, FCPS, FIPP, MHPE

CONTACT

[email protected]

+922134864397 ext. 4397

Sponsors and collaborators

Lead sponsor

Aga Khan University

Other

Registry information

Official study title

Impact of Multimodal Analgesia and ERAS Protocol on Length of Hospital Stay After Laparoscopic Gynecological Surgeries: A Randomized Control Trial

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Aug 11, 2025
Registry last updated
Feb 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.